ライフサイエンスコーパス: enrollee

1 serving substantial numbers of both types of enrollees).

2 nly if an infrastructure exists to serve new enrollees.

3 exists across local communities to serve new enrollees.

4 -based treatment infrastructure for Medicaid enrollees.

5 of death among antiretroviral therapy (ART) enrollees.

6 Infection was confirmed in 60 of 66 (91%) enrollees.

7 e scope of medical services required for new enrollees.

8 gth of stay and these outcomes among hospice enrollees.

9 fitness benefits than among the 4097 earlier enrollees.

10 on rates are primarily derived from Medicare enrollees.

11 ith healthier enrollees to plans with sicker enrollees.

12 % CI, 4.4 to 11.7), as compared with earlier enrollees.

13 was the least common, being reported in 167 enrollees.

14 han that received by commercial managed care enrollees.

15 performed per 1000 Medicare non-managed care enrollees.

16 ries-related treatment visits among Medicaid enrollees.

17 l therapy was identified from all Medicare D enrollees.

18 y insured individuals and Medicare Advantage enrollees.

19 All communities contributed >/=20 enrollees.

20 dermatologists is often limited for Medicaid enrollees.

21 %-64%) at 1 year post discharge among Part D enrollees.

22 ation-level health indicators among Medicare enrollees.

23 mary care for the growing number of Medicaid enrollees.

24 oss Blue Shield of Texas [BCBSTX]) for Texas enrollees.

25 SUD treatment facilities that serve Medicaid enrollees.

26 %); MRI use increased from 17 to 65 per 1000 enrollees, 10% annual growth (95% CI, 3.3%-16.5%); and u

27 Among dual enrollees, 10% exclusively used the VA for outpatient an

28 Seventy-six percent of enrollees (1111/1470) requested to participate in future

29 Among 1 million randomly sampled enrollees, 14 523 adult CHB patients were identified fro

30 Among 9710 enrollees, 1868 (19%) tested positive for influenza A(H3

31 1) outreach/enrollment/uptake and profile of enrollees, (2) impact on insurance coverage and uninsure

32 ribing daily hospital admissions of Medicare enrollees (23.7 million fee-for-service beneficiaries [a

33 Of 152,163 eligible enrollees, 2925 (1.9%) developed POAG.

34 edicine use decreased from 32 to 21 per 1000 enrollees, 3% annual decline (95% CI, 7.7% decline to 1.

35 und rates increased from 134 to 230 per 1000 enrollees, 3.9% annual growth (95% CI, 3.0%-4.9%).

36 Among the 11 161 907 eligible enrollees, 40 892 (0.4%) underwent vitrectomy over the 1

37 During the study period, 81/1,490 enrollees (5.4%) died by suicide.

38 creased after 2004 from 0.24 to 3.6 per 1000 enrollees, 57% annual growth.

39 Among having randomly sampled 1 million enrollees, 6,251 adult CHC patients were identified from

40 During the study period, 655,613 enrollees (68.8%) underwent at least one imaging procedu

41 ical data were obtained prospectively in 146 enrollees (73+/-10 years) undergoing dual chamber pacema

42 At each subsequent appointment, most enrollees (80% to 85%) reported symptoms using the onlin

43 uating rates of bariatric procedures/100,000 enrollees, 90-day mortality, readmission rate and paymen

44 dditional annual hospital admissions per 100 enrollees (95% CI, 1.8 to 2.6), 13.4 more annual inpatie

45 .6), 13.4 more annual inpatient days per 100 enrollees (95% CI, 10.2 to 16.6), and an increase of 0.7

46 19.8 fewer annual outpatient visits per 100 enrollees (95% confidence interval [CI], 16.6 to 23.1),

47 Of 1 381 477 eligible enrollees, 977 (0.1%) developed NAION during a mean +/-

48 Among the 952,352 included first-time enrollees, a 1-star higher rating was associated with a

49 A small subset of enrollees account for a large proportion of all glaucoma

50 to rates among noninstitutionalized Medicare enrollees age 65 and older undergoing the same procedure

51 ed cohort of 73,196 fee-for-service Medicare enrollees age 66 years or older who were diagnosed with

52 ple of 44,511 women fee-for-service Medicare enrollees aged > or = 65 years who were diagnosed with s

53 s during 1999-2005 for >9.3 million Medicare enrollees aged > or =65 years.

54 All enrollees aged >/=21 years in a US managed-care network

55 ort design, a national sample of new veteran enrollees aged 18-35 years was studied.

56 All enrollees aged 21 years or older in a United States mana

57 assessed in 87,736 fee-for-service Medicare enrollees aged 65 years or older diagnosed with advanced

58 pulation of approximately 6 million Medicare enrollees aged 65 years or older.

59 mortality among Cardiovascular Health Study enrollees aged 65-98 years who, at baseline assessment i

60 ulation >200,000) with 11.5 million Medicare enrollees (aged >65 years) living an average of 5.9 mile

61 Enrollees also had higher unadjusted risks of 30-day all

62 Differing distributions of enrollees among health plans accounted for 39 to 59% of

63 proved appointment availability for Medicaid enrollees among participating providers without generati

64 2.3 million to reimburse care provided to MA enrollees and collected $9.4 million (18% of the billed

65 iven low rates of hospice use among Medicaid enrollees and considerable evidence of suffering at the

66 by both increases in the number of Medicare enrollees and in per capita utilization.

67 13 835 noninstitutionalized elderly Medicare enrollees and Medicare enrollees with disabilities, 44%

68 were associated with CRN in elderly Medicare enrollees and Medicare enrollees with disabilities.

69 eadmission for AMI or stroke) between Part D enrollees and nonenrollees, after adjustment for patient

70 ctors, CRN was similar among Medicare Part D enrollees and nonenrollees.

71 ve access to dermatology care among Medicaid enrollees and played an especially important role for th

72 plans, the differences between the 1154 new enrollees and the 3910 earlier enrollees were 1.5 percen

73 sing numbers and diversity of medical school enrollees and the US physician workforce size and compos

74 only plans (serving predominantly commercial enrollees), and Medicaid/commercial plans (serving subst

75 hat met these criteria, stated the number of enrollees, and included a follow-up evaluation that last

76 alizations in a cohort of Tennessee Medicaid enrollees between 1996 and 2004.

77 m 1380 to 1945 biopsies per 100,000 Medicare enrollees between 1997 and 2008, which represents a comp

78 ncreased from 693.9 to 947.2 visits per 1000 enrollees between 1999 and 2007 (rate difference, 253.3;

79 Among Medicare managed care enrollees carrying a diagnosis of RA between 2005 and 20

80 d-only plans (serving predominantly Medicaid enrollees), commercial-only plans (serving predominantly

81 nd the representativeness of the SHIFT trial enrollees compared with those in the Swedish Heart Failu

82 ble women enrolled onto the study and 50% of enrollees completed genetic counseling.

83 ebo capsules enriched with 81 mg aspirin; 46 enrollees completed the trial.

84 and 2002, respectively) for two groups: FEHB enrollees diagnosed in 1999 with bipolar disorder, major

85 on outreach, enrollment, characteristics of enrollees, disenrollment, and coverage dynamics.

86 d from 2001 to 2013 (664 to 1058 per 100,000 enrollees), driven by HCV and nonalcoholic fatty liver d

87 Of the 11 160 833 enrollees eligible for this study, 376 680 (3.4%) had 1

88 nd continued to provide SOC practices to all enrollees: enhanced contact with interventionist (EC) (b

89 Expenditures per enrollee for mental health and substance abuse services

90 her than among noninstitutionalized Medicare enrollees for all procedures (surgery for bleeding duode

91 urred higher expenditures for commercial HMO enrollees for professional, hospital, laboratory, pharma

92 e) in a population of 12 million US Medicare enrollees for the period 2000-2008.

93 d >/=65 years] per year; 85% of all Medicare enrollees) for the period 1999 to 2010 in 1943 counties

94 ed seventy-seven eligible PCPs of consenting enrollees from 8 regional or urban Ontario CR programs w

95 mmercially insured and Medicare managed care enrollees from a large, national US managed care health

96 udy (GHS) cohort that included 4335 eligible enrollees from among 5000 subjects who participated in t

97 parity with follow-up care was increased for enrollees from areas of low income and less education.

98 Of 83 potential enrollees from the DATA study, 77 completed at least one

99 for dementia, AD, and PD among all Medicare enrollees >/= 65 years in 50 northeastern U.S. cities (1

100 cular and respiratory disease among Medicare enrollees >/= 65 years of age during the 12-year period

101 s for cardiovascular diseases among Medicare enrollees >/= 65 years of age.

102 ared with white participants, Asian-American enrollees had a 177% increased risk of developing MH (ad

103 aged-care plan for at least 4 years in which enrollees had at least 2 visits to an eye care provider

104 th acute conjunctivitis by ophthalmologists, enrollees had considerably higher odds of antibiotic pre

105 Enrollees had HCV and were listed for liver transplantat

106 More affluent and educated enrollees had higher odds of filling antibiotic prescrip

107 Compared with eligible nonenrollees, enrollees had higher out-of-pocket expenditures and util

108 Although 76% of enrollees had home computers, only 15% self-reported fro

109 pulations in other states, Massachusetts AQC enrollees had lower spending growth and generally greate

110 ms for a contemporary population of Medicare enrollees has not been studied.

111 Among Medicaid enrollees, HCV/HIV coinfection was associated with incre

112 to a sustained period of slow growth in per-enrollee health care spending and improvements in health

113 Factors associated with being an enrollee in the costliest 5% for glaucoma-related charge

114 riences and current medical needs that a new enrollee in the program might have at the first visit to

115 Among 43 892 enrollees in 173 health plans who were hospitalized for

116 .4% (from 3.2 procedures per 10,000 Medicare enrollees in 1991 to 5.1 procedures per 10,000 in 2010).

117 2% (from 31.2 procedures per 10,000 Medicare enrollees in 1991 to 62.1 procedures per 10,000 in 2010)

118 ; CT examinations increased from 52 per 1000 enrollees in 1996 to 149 per 1000 in 2010, 7.8% annual i

119 Black enrollees in 2006 and 2011 were substantially less likel

120 ferral region rates of PCI per 1000 Medicare enrollees in 2007 on the regions' rates of providing >/=

121 All charts from HMO-health plan enrollees in 2007 were reviewed (n = 1,116).

122 neurologic and allergic adverse events among enrollees in 8 medical care organizations (the Vaccine S

123 For every additional optometrist per 100 000 enrollees in a community, the hazard of surgery increase

124 A total of 340 372 enrollees in a large nationwide United States managed ca

125 s nested case-control study was among female enrollees in a large U.S. integrated health care deliver

126 D PARTICIPANTS: Assessment of the first 1005 enrollees in a multisite, randomized, double-blind, noni

127 Records of almost 8 million enrollees in a national managed-care network throughout

128 Average spending increased for enrollees in both the intervention and control groups in

129 sed all-cause admission rates among Medicare enrollees in each HRR.

130 Medicare enrollees in health plans with insurance parity for ment

131 All electronic medical records for enrollees in Kaiser Permanente Hawaii (n = 217,061) from

132 increased copayments for ambulatory care and enrollees in matched control plans--similar plans that m

133 Among elderly enrollees in Medicare Advantage health plans in 2011 who

134 t the increased use of prescription drugs by enrollees in Medicare Part D has had on spending for oth

135 use of outpatient and inpatient care between enrollees in Medicare plans that increased copayments fo

136 interval [CI], 2.6 to 9.7) among the 755 new enrollees in plans that added fitness benefits than amon

137 in a retrospective cohort study of Medicaid enrollees in Tennessee.

138 usted absolute differences in proportions of enrollees in the 2 years, 7.9 percentage points and 10.3

139 Enrollees in the American College of Radiology Imaging N

140 suspected glaucoma and 127 healthy eyes from enrollees in the Diagnostic Innovations in Glaucoma Stud

141 Participants were enrollees in the Group Health Cooperative (Seattle, Wash

142 Participants were enrollees in the Group Health Cooperative aged 20-79 yea

143 ps in 2009, but the increase was smaller for enrollees in the intervention group--$15.51 (1.9%) less

144 participants were drawn from the first 2,000 enrollees in the National Institute of Mental Health (NI

145 From among 4,107 enrollees in the National Institute of Mental Health's S

146 Subjects were enrollees in the Vitamin D Antenatal Asthma Reduction Tr

147 an increase in the vitrectomy rates per 1000 enrollees in this large managed care network over the co

148 Nearly 60% of enrollees in this managed care network filled antibiotic

149 thma attacks who were randomly selected from enrollees in two health insurance companies by incidence

150 and the quality of care received by Medicaid enrollees, including evidence for disease reduction; and

151 ween 1998 and 2001, utilization per Medicare enrollee increased 16% per year for MR imaging and 7%-15

152 AIT-treated enrollees incurred 38% ($6,637 vs $10,644, P<.0001) lowe

153 a variety of strategies affecting potential enrollees, insurers, and healthcare providers are offere

154 e health plan rather than selection of black enrollees into lower-performing plans.

155 federal financial assistance for Marketplace enrollees, introducing a public plan option in areas lac

156 during screening mammography among Medicare enrollees is associated with increased DCIS incidence, t

157 nts for ambulatory care were magnified among enrollees living in areas of lower income and education

158 ulation of approximately 12 million Medicare enrollees living on average 9 miles (14.4 km) from collo

159 ing a high volume of surgical care for their enrollees may benefit by critically evaluating the syste

160 various racial and ethnic groups of Medicare enrollees may contribute to persistent disparities in he

161 nsurers to provide medical care services for enrollees (Medicaid managed care plans).

162 tigated the impact of Mutuelles' coverage on enrollees' medical care utilization using logistic regre

163 SC diagnosis, including all records from HMO-enrollee members in 2007.

164 We identified all enrollees newly diagnosed with acute conjunctivitis, cal

165 e therapy (IPT) was prescribed to <1% of ART enrollees not taking TB treatment.

166 Among enrollees of 2 US health plans, we compared Papanicolaou

167 Cases and controls were sampled from enrollees of a dental insurance plan with live singleton

168 is conducted among 18- to 49-year-old female enrollees of a large health care system in western Washi

169 82) and non-Hispanic white (NHW; n = 82,696) enrollees of Kaiser Permanente Northern California (KPNC

170 spital admissions among 9.2 million Medicare enrollees of the Northeast/Mid-Atlantic United States be

171 wever, private expenditures for managed care enrollees offset decreased Medicaid expenditures, result

172 Trained field staff posed as either Medicaid enrollees or privately insured enrollees seeking new-pat

173 dequate information on the renal function of enrollees or the effect of interventions on patients wit

174 .4% lower for black enrollees than for white enrollees (P<.001 for all).

175 but not top quintile of facility to Medicaid enrollee per capita ratio), or high access (ie, top quin

176 ss (ie, top quintile of facility to Medicaid enrollee per capita ratio).

177 ding on claims grew an average of $62.21 per enrollee per quarter less than it did in the control coh

178 with a median effective dose of 0.1 mSv per enrollee per year (interquartile range, 0.0 to 1.7).

179 rom imaging procedures was 2.4+/-6.0 mSv per enrollee per year; however, a wide distribution was note

180 ery high doses were incurred in 18.6 and 1.9 enrollees per 1000 per year, respectively.

181 ve doses of radiation were incurred in 193.8 enrollees per 1000 per year, whereas high and very high

182 ases (95% CI 0.63-0.83) per 100,000 Medicaid enrollees per year.

183 Among Medicaid enrollees, performance on the 11 measures observed in th

184 regression assessed factors associated with enrollees' prescription of >/=1 glaucoma medication clas

185 Medicaid managed care enrollees receive lower-quality care than that received

186 The next 190 sequential enrollees received instruction from CEIs.

187 r of gastroenterology procedures per million enrollees remained largely unchanged in Medicare patient

188 The proportion of new enrollees reporting activity limitation was 10.4 percent

189 The proportion of enrollees reporting excellent or very good health was 6.

190 Medicare plans, representing 79% of Medicare enrollees, required greater cost sharing for mental heal

191 Main Outcomes and Measures: Proportion of enrollees requiring additional LTPs, hazard ratio with 9

192 ion classes prescribed and the proportion of enrollees requiring cataract or glaucoma surgery within

193 Among 2351 enrollees, rhinovirus was detected in 247 (11%).

194 In each enrollee's credentialing file, if there was a claim agai

195 Monitoring proportions of enrollees screened for TB, and incidence and determinant

196 ther Medicaid enrollees or privately insured enrollees seeking new-patient primary care appointments.

197 ng and quality of care for another insurer's enrollees served by the ACO.

198 We found no evidence that enrollees shifted their deforestation to nearby land.

199 these findings in a nonrandomized subset of enrollees show an HLA-specific vaccine effect on the tim

200 Among the 322,699 enrollees switching plans, a 1-star higher rating was as

201 factors and type of provider diagnosing the enrollee than by medical indication.

202 e measures was 6.8% to 14.4% lower for black enrollees than for white enrollees (P<.001 for all).

203 ket plans for expenditures of any individual enrollee that exceed a high predetermined level.

204 Among elderly Medicare enrollees, the risk for interval CRC was higher in black

205 aling file, if there was a claim against the enrollee there was a narrative regarding each malpractic

206 Similarly, among commercial enrollees, there was virtually no difference in performa

207 Among Mutuelles enrollees, those in the poorest expenditure quintile had

208 btained from January 26, 2012 (date of first enrollee), through May 1, 2015, to establish participant

209 spending increased from a mean of $2802 per enrollee to $3610 during this period (29% increase).

210 decrease in inpatient spending from $641 per enrollee to $373 and was driven primarily by an increase

211 11 were substantially less likely than white enrollees to have adequate control of blood pressure (ad

212 ve funds from insurance plans with healthier enrollees to plans with sicker enrollees.

213 The estimated VA health care costs for MA enrollees totaled $13.0 billion over 6 years, increasing

214 nt disorder (N=19,094) and privately insured enrollees unaffected by the policy in a comparison natio

215 The proportion of enrollees undergoing >/=1 VF test, FP, OOI, and no testi

216 Medicare enrollees undergoing an elective colectomy at a large te

217 and blacks were underrepresented relative to enrollees undergoing eye care for reasons other than cor

218 During the 15-year study period, enrollees underwent a total of 30.9 million imaging exam

219 A total of 821 Medicare enrollees underwent an elective colectomy and met inclus

220 d previously demonstrated savings among BCBS enrollees varied similarly across settings, services, an

221 All-cause 30-day death was more common among enrollees versus nonenrollees (4.0% versus 3.3%), but th

222 We identified all enrollees visiting an ED for ocular conditions identifie

223 pes, the average wait time for Medicaid-CHIP enrollees was 22 days longer than that for privately ins

224 The median age of enrollees was 27 years (range, 18-50); 52% were White (n

225 The mean age of enrollees was 30.4 +/- 15.7 months.

226 ess to provide appointments for new Medicaid enrollees was related to the size of increases in Medica

227 duced spending and improved quality for BCBS enrollees, was also associated with changes in spending

228 For each enrollee, we quantified medication adherence using the m

229 the 1154 new enrollees and the 3910 earlier enrollees were 1.5 percentage points or less for each me

230 At baseline, enrollees were 45% women, 82% white, mean (SD) age was 6

231 Nasopharyngeal swabs from enrollees were analyzed for the presence of RSV and othe

232 omplete parasitological data of 1860 (86.6%) enrollees were analyzed.

233 s, participants enrolled at sites with fewer enrollees were at higher risk for adverse outcomes (HR:

234 Rates of vitrectomy per 1000 enrollees were computed each year from 2001 through 2012

235 Enrollees were followed from their first prescription un

236 Hispanic enrollees were less likely than whites in 2011 to have a

237 Enrollees were monitored continuously for >/=2 years bet

238 Eligible enrollees were pregnant women ages 18-45.

239 Enrollees were randomized to 2 cohorts: cohort A physici

240 Enrollees were randomly assigned as family units to eith

241 The costliest 5% of enrollees were responsible for $10 202 871 (24%) of all

242 how representative RELAX-AHF clinical trial enrollees were to those patients with AHF found in inter

243 tted to hospitals in Tyrol; 675 (14%) of the enrollees were treated with alteplase.

244 There was no difference in the proportion of enrollees who developed adverse events after keratoplast

245 xperienced CRN, compared with 12% of elderly enrollees who did not report such symptoms.

246 s from a national managed care organization, enrollees who had been prescribed glucocorticoids (taken

247 Of PHS enrollees who had blood collected at PHS II baseline (ap

248 reas of lower income and education and among enrollees who had hypertension, diabetes, or a history o

249 Among 187 enrollees who had received a single implicated drug, ini

250 Of the 659357 enrollees who met inclusion criteria (391674 females and

251 Of the 492,488 enrollees who met inclusion criteria, 2283 (0.5%) develo

252 Of the 38 648 enrollees who met the inclusion criteria, 2187 underwent

253 Of the 494 165 enrollees who met the study inclusion criteria, 1302 (0.

254 data (20% sample) of 15 996 Medicare Part D enrollees who received a DES in 2006 to 2007.

255 e (1.2 mSv vs 2.3 mSv) and the proportion of enrollees who received high (>20-50 mSv) exposure (1.2%

256 The percentage of eligible PacifiCare enrollees who received mammography, Papanicolaou smear s

257 Among elderly enrollees who reported depressive symptoms, 19% experien

258 d care network were analyzed to identify all enrollees who underwent 1 vitrectomy or more each year f

259 By 2010, 6.8% of enrollees who underwent imaging received high annual rad

260 Nearly one-quarter of enrollees who visited the ED for an ocular problem recei

261 Among the 3,625 enrollees who were HIV-negative at enrollment and comple

262 f 0.7 percentage points in the proportion of enrollees who were hospitalized (95% CI, 0.51 to 0.95),

263 ystem (intervention group) and for 1,351,446 enrollees whose PCPs were not in the system (control gro

264 We compared spending and quality among enrollees whose physician organizations entered the AQC

265 We analyzed 2006-2009 claims for 380,142 enrollees whose primary care physicians (PCPs) were in t

266 ording to the ZIP Code of residence for each enrollee with the use of previously validated prediction

267 2217 Kaiser Permanente Northwest health plan enrollees with a history of third molar extraction with

268 d included Medicare and commercial insurance enrollees with a new, adjudicated prescription for any o

269 Among 340 372 enrollees with acute conjunctivitis, 198 462 (58%) fille

270 Total spending was unchanged among enrollees with bipolar disorder and major depression but

271 cohorts that had a disproportionate share of enrollees with chronic mental health and medical conditi

272 Of 9311 enrollees with complete data, 7078 (76%) were influenza

273 ring a 10-year period, spending for Medicaid enrollees with depression increased substantially, with

274 The percentage of enrollees with depression who were hospitalized decrease

275 Among enrollees with disabilities reporting depressive symptom

276 ms, 38% experienced CRN compared with 22% of enrollees with disabilities who did not report depressiv

277 ized elderly Medicare enrollees and Medicare enrollees with disabilities, 44% of beneficiaries with d

278 N in elderly Medicare enrollees and Medicare enrollees with disabilities.

279 Disease severity was important; enrollees with end-organ damage caused by HTN had a 107%

280 Enrollees with established eye care professionals had a

281 e containing more than 1000 eyes of Medicare enrollees with glaucoma who underwent LTP in Oklahoma fr

282 Enrollees with hypertension (HTN) alone (aHR, 1.78; CI,

283 to an HIV behavioral risk study and compared enrollees with men who declined to enroll.

284 For some plans with a high share of enrollees with mental health conditions, underpayment wa

285 plans that have a disproportionate share of enrollees with mental health conditions.

286 Of the 56675 enrollees with newly diagnosed OAG, the mean proportion

287 dence interval [CI], $33 to $50) (74%) among enrollees with no previous drug coverage, $27 higher (95

288 ICD-9CM) billing codes were used to identify enrollees with nonexudative and exudative AMD.

289 Average glaucoma-related charges for enrollees with OAG were characterized in 6-month blocks

290 at the initial LTP was 77.7 (7.5) years for enrollees with ophthalmologist-performed LTP and 77.6 (8

291 Percentage of health plan enrollees with prediabetes who were prescribed metformin

292 extraction with 2217 age-and gender-matched enrollees with radiographic confirmation of no lifetime

293 community-dwelling, nonelderly disabled dual enrollees with schizophrenia (n = 5554) or bipolar disor

294 of elderly beneficiaries: Medicare Advantage enrollees with stable, uncapped, employer-based drug cov

295 esting; and from a reduction in spending for enrollees with the highest expected spending.

296 resulted in increased radiation exposure for enrollees, with a doubling in the mean per capita effect

297 demographics and comorbidities to a Medicare enrollee without cancer, and each pair was followed thro

298 A group of 87,307 Medicare enrollees without cancer were individually matched by ag

299 medical comorbidities to a group of Medicare enrollees without cancer, and each pair was followed thr

300 ased hazard of developing BRVO compared with enrollees without HTN (aHR, 2.07; CI, 1.75-2.45; P < 0.0